Moreover, landscape studies have identified somatic heterozygous mutations in Notch pathway genes, such as NCSTN, APH1, MAML1, and NOTCH2, in 12% of CMML patients [159]. This evidence concerns the gene NCSTN and chronic myelomonocytic leukemia.